| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Advanced BioPhotonics Inc. > News item |
Advanced BioPhotonics, Dartmouth enter into pilot-site research agreement
By Elaine Rigoli
Tampa, Fla., June 15 - Advanced BioPhotonics Inc. and The Dartmouth-Hitchcock Medical Center and Dartmouth Medical School Department of Surgery have formed an agreement in which the university will participate in the company's multi-center clinical trial investigating the use of DIRI method of dynamic infrared imaging in mapping vascular perforator blood vessels in plastic and reconstructive surgery procedures.
"Dartmouth is the third luminary medical center in the United States to join this multi-center trial. The company believes that perforator vessel localization in plastic and reconstructive surgery flap procedures represents an important surgical application that has the potential to shorten OR procedure times by providing surgeons with anatomical information and measurements not readily available today with conventional imaging techniques," said Robert Ellis, senior vice president of Advanced BioPhotonics, in a statement.
To conduct this study, scheduled to begin within two weeks, Dartmouth will use the company's patented BioScanIR System, a functional medical imaging modality that provides a non-invasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue, according to a news release.
The agreement is for a period of one year, the release said.
The company expects at least one additional luminary medical center to join this trial in the next several weeks and expects to conclude the trial in September.
Advanced BioPhotonics, based in Bohemia, N.Y., is a developer of medical imaging applications using infrared technology.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.